The journey in diabetes began 90 years ago and since then, Novo Nordisk has been changing diabetes through innovation, education and collaboration.
Hypoglycaemia or hypos are the result of glucose levels in the blood falling too low; the symptoms may include a pounding heart, trembling, hunger or blurred vision.
More than 480,000 people with diabetes in the UK are being treated with Novo Nordisk medicines.
The symptoms of post-meal or postprandial hyperglycaemia are often not recognised by people with diabetes or are not reported to healthcare professionals.
